Rockwell Medical, Inc. Stock price

Equities

RMTI

US7743743004

Pharmaceuticals

Real-time Estimate Cboe BZX 02:04:59 2024-03-28 pm EDT 5-day change 1st Jan Change
1.655 USD +0.91% Intraday chart for Rockwell Medical, Inc. +9.21% -12.17%
Sales 2024 * 88.97M Sales 2025 * 101M Capitalization 48.11M
Net income 2024 * -2M Net income 2025 * 1M EV / Sales 2024 * 0.54 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.48 x
P/E ratio 2024 *
-16.4 x
P/E ratio 2025 *
27.3 x
Employees 237
Yield 2024 *
-
Yield 2025 *
-
Free-Float 97%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.91%
1 week+9.21%
Current month+17.73%
1 month+22.06%
3 months-14.87%
6 months-17.00%
Current year-12.17%
More quotes
1 week
1.44
Extreme 1.44
1.72
1 month
1.33
Extreme 1.33
1.76
Current year
1.16
Extreme 1.16
1.94
1 year
1.16
Extreme 1.16
6.24
3 years
0.84
Extreme 0.84
13.42
5 years
0.84
Extreme 0.84
66.11
10 years
0.84
Extreme 0.84
207.90
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 22-06-30
Director of Finance/CFO - 23-10-17
Chief Tech/Sci/R&D Officer 63 19-11-19
Members of the board TitleAgeSince
Director/Board Member 65 17-09-06
Director/Board Member 77 20-06-10
Chief Executive Officer 53 22-06-30
More insiders
Date Price Change Volume
24-03-28 1.665 +1.52% 252 889
24-03-27 1.64 -0.61% 254,190
24-03-26 1.65 +1.85% 432,703
24-03-25 1.62 -5.26% 310,515
24-03-22 1.71 +12.50% 643,949

Delayed Quote Nasdaq, March 28, 2024 at 01:49 pm EDT

More quotes
Rockwell Medical, Inc. is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers around the world. It operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. It is the supplier of life-sustaining hemodialysis concentrates products to dialysis clinics. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. Its first two branded products from its ferric pyrophosphate citrate (FPC) platform, Triferic (dialysate) and Triferic AVNU, are indicated to maintain hemoglobin in patients undergoing hemodialysis. It offers dry and liquid citric acid, acetic acid, and bicarbonate hemodialysis products.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1.64 USD
Average target price
7 USD
Spread / Average Target
+326.83%
Consensus
  1. Stock
  2. Equities
  3. Stock Rockwell Medical, Inc. - Nasdaq